ADRC iPS 1 Clone 5 | Fibroblast | Female | 80 | White | Mild Cognitive Impairment | Amnestic Multi-Domain (L) | [ProbAD] | 21 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 21 | 1 | Yes | e3e4 |
ADRC iPS 2 Clone 5 | Fibroblast | Male | 81 | White | Alzheimer Disease | [Non-MCI] | [PossAD] | 15 | 2 | Alzheimer Disease | [Non-MCI] | [PossAD] | 15 | 2 | No | e3e3 |
ADRC iPS 5 Clone 3 | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 4 Clone 15 | Fibroblast | Male | 83 | White | Impaired not MCI | QCI | [PossAD] | 29 | 0.5 | Normal Control | [Non-MCI] | [None] | 27 | 0 | Yes | e3e3 |
ADRC iPS 6 Clone 1 | Fibroblast | Male | 86 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 28 | 0.5 | Alzheimer Disease | [Non-MCI] | [ProbAD] | 28 | 0.5 | No | e4e4 |
ADRC iPS 7 Clone 1 | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 28 | 0 | Alzheimer Disease | [Non-MCI] | [AD] | 26 | 3 | Yes | e3e4 |
ADRC iPS 8 Clone 19 | Fibroblast | Male | 75 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 20 | 1 | Alzheimer Disease | [Non-MCI] | [AD] | 19 | 2 | No | e3e3 |
ADRC iPS 12 Clone 2 | Fibroblast | Male | 75 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 20 | 1 | Alzheimer Disease | [Non-MCI] | [AD] | 19 | 2 | No | e3e3 |
ADRC iPS 21 Clone 1 | Fibroblast | Female | 62 | Chinese | Normal Control | [Non-MCI] | [None] | 29 | 0 | Normal Control | [Non-MCI] | [None] | 28 | 0 | No | e3e3 |
ADRC iPS 13 Clone 2 | Fibroblast | Female | 90+ | White | Mild Cognitive Impairment | Amnestic Multi-Domain (LEV) | [ProbAD] | 29 | 0.5 | Mild Cognitive Impairment | Amnestic Multi-Domain (LEV) | [ProbAD] | 29 | 0.5 | No | e3e3 |
ADRC iPS 24 Clone 2 | Fibroblast | Female | 84 | White | Mild Cognitive Impairment | Amnestic Multi-Domain (LE) | [ProbAD] | 26 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 20 | 2 | Yes | e3e4 |
ADRC iPS 18 Clone 11 | Fibroblast | Female | 70 | White | Mild Cognitive Impairment | Amnestic Multi-Domain (AE) | [Dep] | 28 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 14 | 1 | Yes | e3e3 |
ADRC iPS 46 Clone 5 | Fibroblast | Male | 75 | Chinese | Impaired not MCI | QCI | [PossAD] | 29 | 0 | Impaired not MCI | QCI | [DYSILL] | 26 | 0.5 | No | e2e3 |
ADRC iPS 15 Clone 11 | Fibroblast | Female | 87 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 22 | 1 | Alzheimer Disease | [Non-MCI] | [AD] | 16 | 2 | No | e3e4 |
ADRC iPS 31 Clone 4 | Fibroblast | Male | 81 | White | Mild Cognitive Impairment | Amnestic Multi-Domain (L) | [ProbAD] | 28 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 24 | 1 | Yes | e3e4 |
ADRC iPS 52 Clone 2 | Fibroblast | Female | 75 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e2e3 |
ADRC iPS 25 Clone 1 | Fibroblast | Female | 66 | Chinese | Normal Control | [Non-MCI] | [None] | 28 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 29 Clone 3 | Fibroblast | Male | 75 | White | Dementia-Other | [Non-MCI] | [LBD] | 12 | 2 | Dementia-Other | [Non-MCI] | [LBD][PD] | | 3 | No | e4e4 |
ADRC iPS 20 Clone 2 | Fibroblast | Female | 72 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 22 | 1 | Alzheimer Disease | [Non-MCI] | [AD] | 16 | 2 | No | e4e4 |
ADRC iPS 33 Clone 4 | Fibroblast | Female | 73 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 20 | 2 | Alzheimer Disease | [Non-MCI] | [AD] | | 2 | No | e3e4 |
ADRC iPS 36 Clone 1 | Fibroblast | Female | 61 | Japanese | Mild Cognitive Impairment | Amnestic Multi-Domain (LEV) | [ProbAD] | 27 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 17 | 2 | Yes | e4e4 |
ADRC iPS 69 Clone 1 | Fibroblast | Male | 63 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 23 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 5 | 3 | No | e3e3 |
ADRC iPS 35 Clone 4 | Fibroblast | Female | 77 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 25 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 9 | 3 | No | e3e4 |
ADRC iPS 40 Clone 7 | Fibroblast | Male | 66 | Chinese | Normal Control | [Non-MCI] | [None] | 29 | 0 | Normal Control | [Non-MCI] | [None] | 28 | 0 | No | e2e3 |
ADRC iPS 59 Clone 5 | Fibroblast | Male | 79 | White | Dementia-Other | [Non-MCI] | [LBD] | 22 | 2 | Dementia-Other | [Non-MCI] | [LBD] | | 3 | No | e2e4 |
ADRC iPS 54 Clone 15 | Fibroblast | Female | 86 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e2e3 |
ADRC iPS 23 Clone 1 | Fibroblast | Male | 78 | White | Alzheimer Disease | [Non-MCI] | [PossAD] | 18 | 2 | Alzheimer Disease | [Non-MCI] | [AD] | 7 | 3 | No | e4e4 |
ADRC iPS 32 Clone 4 | Fibroblast | Female | 84 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 24 | 1 | Alzheimer Disease | [Non-MCI] | [AD] | | 2 | No | e3e4 |
ADRC iPS 60 Clone 3 | Fibroblast | Female | 86 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 21 | 2 | Alzheimer Disease | [Non-MCI] | [AD] | 22 | 2 | No | e3e4 |
ADRC iPS 56 Clone 10 | Fibroblast | Male | 79 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 1 | 3 | Alzheimer Disease | [Non-MCI] | [ProbAD] | 1 | 3 | No | e3e4 |
ADRC iPS 28 Clone 3 | Fibroblast | Female | 81 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (L) | [AD] | -5 | 0.5 | Yes | e2e2 |
ADRC iPS 17 Clone 14 | Peripheral Blood Mononuclear Cells | Male | 72 | White | Mild Cognitive Impairment | Amnestic | [ProbAD] | 24 | 0.5 | Impaired not MCI | QCI | [PTSD] | 30 | 0 | Yes | e3e4 |
ADRC iPS 16 Clone 5 | Peripheral Blood Mononuclear Cells | Male | 81 | White | Mild Cognitive Impairment | Amnestic Multi-Domain (L) | [PossAD] | 28 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 17 | 2 | Yes | e3e4 |
ADRC iPS 14 Clone 5 | Fibroblast | Male | 87 | White | Mild Cognitive Impairment | Amnestic | [ProbAD] | 26 | 0.5 | Mild Cognitive Impairment | Amnestic | [ProbAD] | 26 | 0.5 | No | e3e3 |
ADRC iPS 34 Clone 2 | Fibroblast | Female | 66 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 16 | 1 | Alzheimer Disease | [Non-MCI] | [AD] | | 2 | No | e3e4 |
ADRC iPS 22 Clone 9 | Fibroblast | Female | 81 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 22 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | | 3 | No | e3e3 |
ADRC iPS 19 Clone 3 | Fibroblast | Female | 75 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LA) | [AD] | 29 | 0.5 | Yes | e2e3 |
ADRC iPS 20 Clone 6 | Fibroblast | Female | 72 | White | Alzheimer Disease | [Non-MCI] | [AD] | 24 | 1 | Alzheimer Disease | [Non-MCI] | [AD] | 16 | 2 | No | e4e4 |
ADRC iPS 27 Clone 14 | Peripheral Blood Mononuclear Cells | Male | 54 | White | Mild Cognitive Impairment | Amnestic Multi-Domain (L) | [PossAD] | 29 | 0.5 | Mild Cognitive Impairment | Amnestic Multi-Domain (LA) | [AD] | 30 | 0.5 | No | e3e3 |
ADRC iPS 26 Clone 5 | Peripheral Blood Mononuclear Cells | Female | 65 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 66 Clone 3 | Fibroblast | Male | 83 | White | Impaired not MCI | QCI | [AD] | 29 | 0.5 | Mild Cognitive Impairment | Amnestic Multi-Domain (LV) | [AD] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 55 Clone 1 | Fibroblast | Female | 75 | White | Dementia-Other | [Non-MCI] | [LBD] | 21 | 1 | Dementia-Other | [Non-MCI] | [LBD] | 17 | -5 | No | e3e3 |
ADRC iPS 75 Clone 5 | Peripheral Blood Mononuclear Cells | Male | 64 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (L) | [AD] | 26 | 0.5 | Yes | e3e3 |
ADRC iPS 76 Clone 4 | Peripheral Blood Mononuclear Cells | Male | 83 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 77 Clone 7 | Peripheral Blood Mononuclear Cells | Male | 77 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Impaired not MCI | QCI | [MEDS] | 30 | 0 | Yes | e3e3 |
ADRC iPS 80 Clone 4 | Fibroblast | Female | 77 | Black | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 62 Clone 4 | Fibroblast | Female | 68 | Black | | | | | | Normal Control | [Non-MCI] | [None] | 28 | 0 | No | e3e3 |
ADRC iPS 64 Clone 6 | Fibroblast | Female | 90+ | White | Alzheimer Disease | [Non-MCI] | [AD] | 14 | 2 | Alzheimer Disease | [Non-MCI] | [AD] | | 3 | No | e3e3 |
ADRC iPS 5 Clone 4 | Peripheral Blood Mononuclear Cells | Female | 69 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 88 Clone 2 | Peripheral Blood Mononuclear Cells | Male | 63 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 23 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 5 | 3 | No | e3e3 |
ADRC iPS 89 Clone 2 | Peripheral Blood Mononuclear Cells | Male | 71 | White | Mild Cognitive Impairment | Amnestic | [PossAD] | 29 | 0.5 | Mild Cognitive Impairment | Amnestic | [PossAD] | 29 | 0.5 | No | e3e3 |
ADRC iPS 26 Clone 8 | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 27 Clone 2 | Fibroblast | Male | 55 | White | Mild Cognitive Impairment | Amnestic Multi-Domain (L) | [PossAD] | 29 | 0.5 | Mild Cognitive Impairment | Amnestic Multi-Domain (LA) | [AD] | 30 | 0.5 | No | e3e3 |
ADRC iPS 96 Clone 2 | Fibroblast | Female | 72 | White | Alzheimer Disease | [Non-MCI] | [AD] | 21 | 1 | Alzheimer Disease | [Non-MCI] | [AD] | 12 | 2 | No | e4e4 |
ADRC iPS 68 Clone 1 | Fibroblast | Male | 77 | White | Mild Cognitive Impairment | Amnestic Multi-Domain (L) | [AD] | 23 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 25 | 2 | Yes | e3e3 |
ADRC iPS 65 Clone 3 | Fibroblast | Female | 52 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e4e4 |
ADRC iPS 107 Clone 1 | Fibroblast | Female | 80 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Normal Control | [Non-MCI] | [None] | 29 | 0 | No | e3e3 |
ADRC iPS 63 Clone 5 | Fibroblast | Female | 75 | American Indian | Normal Control | [Non-MCI] | [None] | 29 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 130 Clone 4 | Fibroblast | Male | 79 | White | Mild Cognitive Impairment | Amnestic Multi-Domain (E) | [AD] | 30 | 0.5 | Alzheimer Disease | [Non-MCI] | [AD] | 29 | 1 | Yes | e3e3 |
ADRC iPS 53 Clone 3 | Fibroblast | Female | 76 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 67 Clone 8 | Fibroblast | Male | 85 | White | Alzheimer Disease | [Non-MCI] | [AD] | 16 | 2 | Alzheimer Disease | [Non-MCI] | [AD] | | 3 | No | e3e3 |
ADRC iPS 59 Clone 8 | Fibroblast | Male | 79 | White | Dementia-Other | [Non-MCI] | [LBD] | 22 | 2 | Dementia-Other | [Non-MCI] | [LBD] | | 3 | No | e2e4 |
ADRC iPS 60 Clone 1 | Fibroblast | Female | 86 | White | Alzheimer Disease | [Non-MCI] | [ProbAD] | 21 | 2 | Alzheimer Disease | [Non-MCI] | [AD] | 22 | 2 | No | e3e4 |
ADRC iPS 76 CSF1R I794T het | Peripheral Blood Mononuclear Cells | Male | 83 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 76 CSF1R E633K het | Peripheral Blood Mononuclear Cells | Male | 83 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 76 CSF1R G795A homo KI | Peripheral Blood Mononuclear Cells | Male | 83 | White | Normal Control | [Non-MCI] | [None] | 30 | 0 | Normal Control | [Non-MCI] | [None] | 30 | 0 | No | e3e3 |
ADRC iPS 5 TREM2 homo KO | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 5 TREM2 het KO | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 5 APOE homo KO | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 5 APOE het KO | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 5 PLCG2 homo KO | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 5 PLCG2 het KO | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 5 PLCG2 P522R homo KI | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |
ADRC iPS 5 PLCG2 P522R het KI | Fibroblast | Female | 67 | White | Normal Control | [Non-MCI] | [None] | 29 | 0 | Mild Cognitive Impairment | Amnestic Multi-Domain (LAE) | [Dep] | 29 | 0.5 | Yes | e3e3 |